SOPHiA GENETICS SA(SOPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SOPH SOPHiA GENETICS SA

Market Closed 12-12 16:00:00 EST

4.75

-0.05

-1.04%

盘后4.75

+0.000.00%

16:10 EST

High4.81	Low4.53	Vol116.57K
Open4.81	D1 Closing4.80	Amplitude5.83%
Mkt Cap322.27M	Tradable Cap240.87M	Total Shares67.85M
T/O544.75K	T/O Rate0.23%	Tradable Shares50.71M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SOPH","market":"US","secType":"STK","nameCN":"SOPHiA GENETICS SA","latestPrice":4.75,"timestamp":1765573200000,"preClose":4.8,"halted":0,"volume":116566,"hourTrading":{"tag":"盘后","latestPrice":4.75,"preClose":4.75,"latestTime":"16:10 EST","volume":2,"amount":9.5,"timestamp":1765573804126},"delay":0,"floatShares":50710302,"shares":67847058,"eps":-1.11662,"marketStatus":"Market Closed","change":-0.05,"latestTime":"12-12 16:00:00 EST","open":4.81,"high":4.81,"low":4.53,"amount":544753.302433,"amplitude":0.058333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.11662,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1627012800000,"exchange":"NASDAQ","adjPreClose":4.8,"preHourTrading":{"tag":"盘前","latestPrice":4.8,"preClose":4.8,"latestTime":"08:53 EST","volume":131,"amount":628.8,"timestamp":1765547604396},"postHourTrading":{"tag":"盘后","latestPrice":4.75,"preClose":4.75,"latestTime":"16:10 EST","volume":2,"amount":9.5,"timestamp":1765573804126},"volumeRatio":1.6622270647465796,"impliedVol":0.9516,"impliedVolPercentile":0.112},"requestUrl":"/m/hq/s/SOPH","defaultTab":"news","newsList":[{"id":"2589859798","title":"Sophia Genetics SA Partners with Tyrolpath to Launch MSK-IMPACT Flex in Austria","url":"https://stock-news.laohu8.com/highlight/detail?id=2589859798","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589859798?lang=en_us&edition=fundamental","pubTime":"2025-12-05 09:16","pubTimestamp":1764897391,"startTime":"0","endTime":"0","summary":"Sophia Genetics SA has partnered with Tyrolpath, the largest private pathology lab in western Austria, to bring advanced precision oncology solutions to the country. Through this collaboration, Tyrolpath will be the first lab in Austria to adopt MSK-IMPACT-Flex powered by the SOPHiA DDM Platform. This integration leverages the proven MSK-IMPACT assay from Memorial Sloan Kettering Cancer Center and SOPHiA GENETICS' cloud-based data analysis platform, enabling cost-efficient, flexible, and comprehensive genomic profiling  of solid tumors. The partnership aims to enhance cancer testing and advance precision oncology for Austrian patients, addressing the growing need for actionable genomic insights in cancer care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL91Jgd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4539","SOPH"],"gpt_icon":0},{"id":"2586279930","title":"Sophia Genetics Partners with Genos Médica to Advance Precision Medicine in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2586279930","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586279930?lang=en_us&edition=fundamental","pubTime":"2025-11-28 09:06","pubTimestamp":1764291977,"startTime":"0","endTime":"0","summary":"Sophia Genetics SA has expanded its collaboration with Genos Médica, a leading genetic and genomic medicine provider in Mexico. Through this partnership, Genos Médica will utilize the SOPHiA DDM Enhanced Whole Exome and Liquid Biopsy applications to strengthen its research in rare disease and oncology. The alliance aims to empower Genos Médica to uncover new insights into genetic variation, supporting the growth of precision medicine across Mexico and Latin America.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL1jpbTM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SOPH","BK4539"],"gpt_icon":0},{"id":"2582360909","title":"Sophia Genetics, Complete Genomics Collaborate to Expand Access to Precision Oncology Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582360909","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582360909?lang=en_us&edition=fundamental","pubTime":"2025-11-11 23:01","pubTimestamp":1762873305,"startTime":"0","endTime":"0","summary":"Sophia Genetics  and Complete Genomics said Tuesday they are collaborating to expand access to precision oncology testing.Sophia Genetics will integrate its MSK-IMPACT and MSK-ACCESS applications with sequencing technology from Complete Genomics to deliver an integrated, sample-to-report workflow for cancer genomic profiling, the companies said.Shares of Sophia Genetics were up over 3% in recent trading.Price: 4.45, Change: +0.10, Percent Change: +2.18","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4167","BK4539","SOPH"],"gpt_icon":0},{"id":"2582362815","title":"Sophia Genetics Collaborating With Element Biosciences to Combine Sequencing, AI Analytics","url":"https://stock-news.laohu8.com/highlight/detail?id=2582362815","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582362815?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:01","pubTimestamp":1762869685,"startTime":"0","endTime":"0","summary":"Sophia Genetics  said Tuesday it entered into a partnership with biology firm Element Biosciences aiming to combine sequencing and AI analytics to streamline genomic workflows.The collaboration will integrate Sophia Genetics' AI-powered analytics platform, Sophia DDM, with Element's AVITI24 5D multiomic and AVITI sequencing systems to deliver an end-to-end workflow for next-generation sequencing, the company said.Shares of Sophia Genetics were 5.8% higher in premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4167","SOPH","BK4539"],"gpt_icon":0},{"id":"2582690133","title":"SOPHiA GENETICS Partners with Element Biosciences to Advance Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2582690133","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582690133?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:01","pubTimestamp":1762866092,"startTime":"0","endTime":"0","summary":"SOPHiA GENETICS and Element Biosciences have announced a partnership to combine Element's AVITI sequencing systems with SOPHiA GENETICS' AI-driven analytics platform. The collaboration aims to streamline genomic workflows and accelerate research in precision medicine by making advanced sequencing and data analysis more accessible to healthcare organizations worldwide. Both companies emphasize that the integration will deliver richer insights, faster results, and greater scalability, supporting the global expansion of precision medicine initiatives.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via PR Newswire  on November 11, 2025, and is solely respons","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDLbfl0nN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SOPH","BK4167"],"gpt_icon":0},{"id":"2582873534","title":"BTIG Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873534?lang=en_us&edition=fundamental","pubTime":"2025-11-10 19:56","pubTimestamp":1762775777,"startTime":"0","endTime":"0","summary":"BTIG analyst Mark Massaro reiterated a Buy rating on SOPHiA GENETICS yesterday and set a price target of $7.00. According to TipRanks, Massaro is a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-their-buy-rating-for-sophia-genetics-soph-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-their-buy-rating-for-sophia-genetics-soph-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOPH"],"gpt_icon":0},{"id":"2582824168","title":"SOPHiA GENETICS Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2582824168","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582824168?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:02","pubTimestamp":1762768920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SOPH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 05:02 ET (10:02 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOPH","BK4539","BK4167"],"gpt_icon":0},{"id":"2580582127","title":"SOPHiA GENETICS SA reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2580582127","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580582127?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:32","pubTimestamp":1762266743,"startTime":"0","endTime":"0","summary":"SOPHiA GENETICS SA reports results for the quarter ended September 30 - Earnings SummarySOPHiA GENETICS SA SOPH.OQ reported a quarterly adjusted loss of 28 cents per share for the quarter ended Septem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL8N3WG20P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOPH","BK4539","BK4167"],"gpt_icon":0},{"id":"2580384787","title":"Press Release: SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2580384787","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580384787?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:45","pubTimestamp":1762256700,"startTime":"0","endTime":"0","summary":"BOSTON and ROLLE, Switzerland, Nov. 4, 2025 /PRNewswire/ -- SOPHiA GENETICS , a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended September 30, 2025.-- Revenue was $19.5 million, up 23% year-over-year. -- Gross margin was 66.3% on a reported basis and 73.1% on an adjusted basis,compared to 67.2% reported and 73.1% adjusted in the prior year period. -- Net IFRS loss was $20.0 million, up 9% year-over-year; Adjusted EBITDA. loss was $10.2 million, up 8% year-over-year; Excluding the impact of. share price appreciation, adjusted EBITDA loss would have been $8.8. million, representing year-over-year growth of 15% to 18%. This compares. to the prior range of $72 to $76 million.\"Q3 was an excellent quarter for SOPHiA GENETICS, with revenue growth accelerating for a third consecutive quarter to 23% as new business continues to come online,\" said Jurgi Camblong, PhD., Chief Executive Officer and Co-founder. \"We also demonstrated strong ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","R","BK4604","NGS","BK4099","TM","BK4179","BK4022","03160","BK4585","SOPH","BK4539","BK4588","BK4167","BK4232"],"gpt_icon":0},{"id":"2580780803","title":"Sophia Genetics Q3 EPS $(0.30) Misses $(0.23) Estimate, Sales $19.462M Beat $18.125M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2580780803","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580780803?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:25","pubTimestamp":1762255537,"startTime":"0","endTime":"0","summary":"Sophia Genetics Q3 EPS $(0.30) Misses $(0.23) Estimate, Sales $19.462M Beat $18.125M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48615239/sophia-genetics-q3-eps-0-30-misses-0-23-estimate-sales-19-462m-beat-18-125m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4167","SOPH"],"gpt_icon":0},{"id":"2580078031","title":"Sophia Genetics SA reports Q3 revenue of $19.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580078031","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580078031?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:24","pubTimestamp":1762255496,"startTime":"0","endTime":"0","summary":"Sophia Genetics SA reported revenue of $19.5 million for the three months ended September 30, 2025, up from $15.9 million in the same period of 2024. For the nine months ended September 30, 2025, revenue reached $55.6 million, compared to $47.4 million for the same period in 2024. Gross profit for the third quarter of 2025 was $12.9 million, up from $10.7 million a year earlier, with a nine-month gross profit of $37.4 million versus $31.8 million in 2024. The total comprehensive loss for the three months ended September 30, 2025, was $20.2 million, compared to a loss of $11.6 million for the same period in 2024. The company continues to operate in a single segment, with no significant changes reported in financial risk management.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL2W4vb5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SOPH","BK4167"],"gpt_icon":0},{"id":"2580223873","title":"Myriad Genetics Q3 revenue beats on volume growth in hereditary cancer testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2580223873","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580223873?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:15","pubTimestamp":1762204517,"startTime":"0","endTime":"0","summary":"Myriad Genetics Q3 revenue beats on volume growth in hereditary cancer testingOverviewMyriad Genetics Q3 2025 revenue declines 4% yr/yr, beats analyst expectationsAdjusted operating income for Q3 beat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL1N3WF117:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7KXQ091.USD","LU1084165304.USD","IE00BFXG1179.USD","LU0861579265.USD","LU1057294990.SGD","LU0672654240.SGD","LU2023251221.USD","LU0965509010.AUD","LU2089283258.USD","IE00BWXC8680.SGD","LU0345770993.USD","MYGN","LU0114720955.EUR","LU0787776722.HKD","LU1548497426.USD","SG9999018865.SGD","BK4167","LU0211326839.USD","IE00BKVL7J92.USD","LU1732800096.USD","IE00BFSS7M15.SGD","SGXZ57979304.SGD","BK4566","LU0211326755.USD","LU0943347566.SGD","LU1854104046.USD","LU0965509283.SGD","IE000M9KFDE8.USD","LU1814569148.SGD","IE0002141913.USD","LU1267930573.SGD","SG9999014898.SGD","LU0820562030.AUD","LU0029864427.USD","LU0234572021.USD","SOPH","LU0345770308.USD","IE00B19Z8X17.USD","LU0128525929.USD","SG9999001176.USD","LU0882574055.USD","LU1720051108.HKD","LU0354030438.USD","LU0683600562.USD","IE00B19Z9505.USD","LU0354030511.USD","LU0912757837.SGD","LU0187121727.USD","LU2087625088.SGD"],"gpt_icon":1},{"id":"2579449671","title":"Craig-Hallum Keeps Their Buy Rating on SOPHiA GENETICS (SOPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579449671","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579449671?lang=en_us&edition=fundamental","pubTime":"2025-10-31 23:26","pubTimestamp":1761924361,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst William Bonello maintained a Buy rating on SOPHiA GENETICS today. The company’s shares opened today at $5.26. According to Tip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-keeps-their-buy-rating-on-sophia-genetics-soph-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-keeps-their-buy-rating-on-sophia-genetics-soph-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOPH"],"gpt_icon":0},{"id":"2579498548","title":"SOPHiA GENETICS SA  expected to post a loss of 24 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2579498548","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579498548?lang=en_us&edition=fundamental","pubTime":"2025-10-31 22:04","pubTimestamp":1761919447,"startTime":"0","endTime":"0","summary":"SOPHiA GENETICS SA  expected to post a loss of24cents a share - Earnings Preview SOPHiA GENETICS SA SOPH.OQ, SOPH.O is expected to  show a rise in quarterly revenue when it reports  results on Novembe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC1JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SOPH","BK4539"],"gpt_icon":0},{"id":"2578794735","title":"Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH) and Sanofi (OtherSNYNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2578794735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578794735?lang=en_us&edition=fundamental","pubTime":"2025-10-25 15:40","pubTimestamp":1761378026,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SOPHiA GENETICS (SOPH – Research Report) and Sanofi ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sophia-genetics-soph-and-sanofi-othersnynf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sophia-genetics-soph-and-sanofi-othersnynf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SOPH","BK4588","BK4581","BK4007","BK4137","XBI","XLV","HCSG","LABU","LU0029874061.USD","BK4539","BK4167","SNYNF","LU0128526141.USD"],"gpt_icon":0},{"id":"2577193827","title":"Sophia Genetics SA to Release Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2577193827","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577193827?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:00","pubTimestamp":1761048039,"startTime":"0","endTime":"0","summary":"SOPHiA GENETICS will announce its third quarter 2025 financial results on November 4, 2025. The results will be released before U.S. markets open and a conference call will be held at 8:00 a.m. EDT / 2:00 p.m. CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website, where a replay will also be available.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via PR Newswire  on October 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDLbKGg6l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SOPH","BK4167"],"gpt_icon":0},{"id":"2575899725","title":"Sophia Genetics, A.D.A.M Partner in Cancer Testing in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2575899725","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575899725?lang=en_us&edition=fundamental","pubTime":"2025-10-16 23:49","pubTimestamp":1760629748,"startTime":"0","endTime":"0","summary":"Sophia Genetics  and A.D.A.M. Innovations said Thursday they are partnering to bring liquid biopsy genomic testing to Japan.The companies said they will also partner to commercialize a liquid biopsy companion diagnostic for personalized and precision cancer care in the country.Shares of Sophia were up over 4% in recent trading.Price: 4.47, Change: +0.18, Percent Change: +4.17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","SOPH","BK4167"],"gpt_icon":0},{"id":"2575723878","title":"Sophia Genetics, A.D.A.M Genetics partner for liquid biopsy testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575723878","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575723878?lang=en_us&edition=fundamental","pubTime":"2025-10-16 23:05","pubTimestamp":1760627118,"startTime":"0","endTime":"0","summary":"A.D.A.M. Innovations and SOPHiA GENETICS (SOPH) announced at ESMO a strategic agreement to bring liquid biopsy genomic testing to the Japanese popu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sophia-genetics-a-d-a-m-genetics-partner-for-liquid-biopsy-testing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sophia-genetics-a-d-a-m-genetics-partner-for-liquid-biopsy-testing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","SOPH","BK4167"],"gpt_icon":0},{"id":"2575271812","title":"Sophia Genetics Unveils AI-Powered Digital Twins to Advance Precision Oncology and Improve Treatment Decision-Making","url":"https://stock-news.laohu8.com/highlight/detail?id=2575271812","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575271812?lang=en_us&edition=fundamental","pubTime":"2025-10-16 16:01","pubTimestamp":1760601690,"startTime":"0","endTime":"0","summary":"SOPHiA GENETICS has announced the launch of SOPHiA DDM Digital Twins, an AI-powered technology designed to enhance intelligent decision-making in oncology. The Digital Twins platform creates dynamic virtual representations of individual patients using clinical, biological, imaging, and genomic data, enabling oncologists to simulate treatment responses and disease trajectories in real time. The technology aims to help match patients with the most effective therapies, reduce exposure to ineffective treatments, and improve precision medicine in cancer care. The announcement states that Digital Twins is launching for lung cancer on the SOPHiA DDM Platform, with additional cancer types to follow. These results and the new platform will be presented at the ESMO conference in Berlin, Germany, from October 17 to 21.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gene","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL2Sw8tB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SOPH","BK4539"],"gpt_icon":0},{"id":"2574171189","title":"SOPHiA GENETICS SA  expected to post a loss of 24 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2574171189","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574171189?lang=en_us&edition=fundamental","pubTime":"2025-10-10 21:27","pubTimestamp":1760102872,"startTime":"0","endTime":"0","summary":"SOPHiA GENETICS SA  expected to post a loss of24cents a share - Earnings Preview SOPHiA GENETICS SA SOPH.OQ, SOPH.O is expected to  show a rise in quarterly revenue when it reports  results on October","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nL5N3VR0TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4539","SOPH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sophiagenetics.com","stockEarnings":[{"period":"1week","weight":-0.0206},{"period":"1month","weight":0.0995},{"period":"3month","weight":0.5224},{"period":"6month","weight":0.6551},{"period":"1year","weight":0.446},{"period":"ytd","weight":0.5472}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.100171},{"month":2,"riseRate":0.75,"avgChangeRate":0.024645},{"month":3,"riseRate":0.25,"avgChangeRate":0.101519},{"month":4,"riseRate":0.25,"avgChangeRate":-0.060294},{"month":5,"riseRate":0,"avgChangeRate":-0.108074},{"month":6,"riseRate":0.25,"avgChangeRate":-0.053781},{"month":7,"riseRate":0.25,"avgChangeRate":-0.057093},{"month":8,"riseRate":0.4,"avgChangeRate":-0.032571},{"month":9,"riseRate":0.4,"avgChangeRate":0.011073},{"month":10,"riseRate":0.4,"avgChangeRate":0.025423},{"month":11,"riseRate":0.4,"avgChangeRate":0.012229},{"month":12,"riseRate":0.4,"avgChangeRate":-0.012452}],"exchange":"NASDAQ","name":"SOPHiA GENETICS SA","nameEN":"SOPHiA GENETICS SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SOPHiA GENETICS SA(SOPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SOPHiA GENETICS SA(SOPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SOPHiA GENETICS SA,SOPH,SOPHiA GENETICS SA股票,SOPHiA GENETICS SA股票老虎,SOPHiA GENETICS SA股票老虎国际,SOPHiA GENETICS SA行情,SOPHiA GENETICS SA股票行情,SOPHiA GENETICS SA股价,SOPHiA GENETICS SA股市,SOPHiA GENETICS SA股票价格,SOPHiA GENETICS SA股票交易,SOPHiA GENETICS SA股票购买,SOPHiA GENETICS SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SOPHiA GENETICS SA(SOPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SOPHiA GENETICS SA(SOPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction